Skip to content

Field Shape and Amplitude Sensitivity Exploratory Study (CONTOUR Study)

Field Shape and Amplitude Sensitivity Exploratory Study (CONTOUR Study)

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02916498
Enrollment
16
Registered
2016-09-27
Start date
2017-02-07
Completion date
2018-07-23
Last updated
2021-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Neuropathic Pain in the Low Back and Legs

Keywords

chronic neuropathic pain in the low back and legs, subperception spinal cord stimulation

Brief summary

The study aims to better understand how to program Spinal Cord Stimulation for the treatment of chronic low back and leg pain

Interventions

DEVICEBoston Scientific's Precision SPECTRA™ Spinal Cord Stimulation System

Spinal cord stimulation for the management of chronic neuropathic pain

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Documented average low back pain intensity of at least 6 out of 10 and greater or equal than average leg pain intensity over 7 days during screening (Numerical Rating Scale) * Stable daily pain-related medication prescription and intake of ≤100mg morphine-equivalents * Capacity to describe and rate pain intensity, complete study measurements, and use the study device (e.g. patient remote control, charger, diary ratings) (physician discretion) Key

Exclusion criteria

* Presence of pain or psychological condition that in the opinion of the investigator may interfere with the subject's ability to rate their pain and communicate such ratings * Previous Spinal Cord Stimulation trial or is already implanted with an active implantable device(s) (e.g. pacemaker, drug pump, implantable pulse generator)

Design outcomes

Primary

MeasureTime frameDescription
Patient Preferred Field Shape42 days post randomizationNumber of participants preferring bipolar field shape and alternative field shape

Countries

United Kingdom

Participant flow

Pre-assignment details

16 subjects were enrolled in the study. 10 were withdrawn prior to randomization. 6 were randomized. Statistically relevant conclusions cannot be made from this small sample size.

Participants by arm

ArmCount
Bipolar Then Alternative Field Shape Stimulation
Boston Scientific's Precision SPECTRA™ Spinal Cord Stimulation System: Spinal cord stimulation for the management of chronic neuropathic pain programmed with bipolar stimulation for 21 days, then alternative field shape stimulation for 21 days
2
Alternative Then Bipolar Field Shape Stimulation
Boston Scientific's Precision SPECTRA™ Spinal Cord Stimulation System: Spinal cord stimulation for the management of chronic neuropathic pain programmed with alternative field shape stimulation for 21 days, then bipolar stimulation for 21 days
4
Total6

Baseline characteristics

CharacteristicAlternative Then Bipolar Field Shape StimulationTotalBipolar Then Alternative Field Shape Stimulation
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants3 Participants0 Participants
Age, Categorical
Between 18 and 65 years
1 Participants3 Participants2 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United Kingdom
4 participants6 participants2 participants
Sex: Female, Male
Female
2 Participants2 Participants0 Participants
Sex: Female, Male
Male
2 Participants4 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 6
other
Total, other adverse events
0 / 60 / 6
serious
Total, serious adverse events
0 / 60 / 6

Outcome results

Primary

Patient Preferred Field Shape

Number of participants preferring bipolar field shape and alternative field shape

Time frame: 42 days post randomization

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Bipolar Then Alternative Field Shape StimulationPatient Preferred Field ShapePreferred Bipolar Field Shape2 Participants
Bipolar Then Alternative Field Shape StimulationPatient Preferred Field ShapePreferred Alternative Field Shape0 Participants
Alternative Then Bipolar Field Shape StimulationPatient Preferred Field ShapePreferred Bipolar Field Shape2 Participants
Alternative Then Bipolar Field Shape StimulationPatient Preferred Field ShapePreferred Alternative Field Shape2 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026